Company Overview and News

 
Are Equity Markets’ Valuations Stretched?

2018-04-20 marketrealist
The International Monetary Fund (or IMF) also warned that the downside risks to world financial stability have increased over the past six months. It added that investors “should not take too much comfort” that the implications of the sharp sell-off in February 2018 didn’t lead to any major disruptions. In this context, it added, “Valuations of risky assets are still stretched, with some late-stage credit cycle dynamics emerging, reminiscent of the pre-crisis period.
Upvote Downvote

 
Looking For Exposure To Silver? Consider Wheaton Precious Metals

2018-04-19 seekingalpha
It looks like the precious metals market is preparing for another leg up. If that is the case, silver should perform better than gold.
Upvote Downvote

 
How Market Uncertainty Affected Precious Metals

2018-04-19 marketrealist
Unrest in Syria played a role in precious metals rising on Friday, April 13. The day before, Donald Trump discussed how to address a recent Syrian poison gas attack. He threatened missile strikes, which were eventually carried out, on Saturday.
Upvote Downvote

 
How Mining Stocks Performed on April 16

2018-04-17 marketrealist
Usually, precious metal mining companies follow precious metals for price direction. Precious metals increased on Monday, April 16, 2018, which was followed by most mining shares.
Upvote Downvote

 
Increased Volatility and Gold Investors

2018-04-17 marketrealist
While gold miners have been out of favor for a long time, that might be about to change. Since the uncertainty in the market is increasing, gold prices are poised to rise. This rise should be followed by gold miners (GDX), which are essentially a leveraged play on gold prices. Moreover, gold miners as a group have emerged as much stronger, leaner, and more competitive after their mistimed deals at the peak of the cycle, leading to debt escalations and substantial write-offs.
Upvote Downvote

 
How Fall of the Dollar Is Impacting Precious Metals and Miners

2018-04-17 marketrealist
One of the market indicators for gold that has been consistently playing a significant role in the determination of the directional move for precious metals is the US dollar, depicted by the Dollar Index (or DXY). It prices the dollar against a basket of six major world currencies. The dollar has fallen 2.9% since the beginning of 2018. During that time, gold has risen 3.3%. The other three precious metals have fallen.
Upvote Downvote

1
3 Gold Mining Stocks That Are Waking Up

2018-04-16 investorplace
Gold stocks are percolating. And while much work remains before their long-term technicals turn bullish, the whole sector could be worth a trade here.
Upvote Downvote

 
7 Gold Stocks That Will Only Get Better This Spring

2018-04-13 investorplace
It’s one of the toughest questions to answer this year: amid all the fears and uncertainties in the broader markets, why haven’t gold stocks jumped in valuation? The traditional safe haven asset hasn’t looked good since collapsing in 2013. And despite some promising developments, every move up is seemingly fiercely contested.
Upvote Downvote

 
Reading the Movements of Miners’ Correlations with Gold

2018-04-12 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Royal Gold (RGLD), Goldcorp (GG), Sibanye Gold (SBGL), and Gold Fields (GFI). Mining stocks mostly move with gold prices, but not always. Among these four miners, Gold Fields has shown the highest correlation with gold, while Royal Gold has seen the lowest correlation with gold on a YTD (year-to-date) basis.
Upvote Downvote

 
What Global News Does to Gold and Miners

2018-04-11 marketrealist
The overall volatility in the markets has played a vital role in determining the directional move for precious metals. Gold and silver rose on Tuesday, April 10, 2018, possibly due to reports of a poison gas attack in Syria and the ongoing trade war fears between China and the United States. The equities market in Asia also lagged on Tuesday, which could have prompted some haven bids for precious metals.
Upvote Downvote

 
Royal Gold (RGLD) Provides Updates on Operations for Q3

2018-04-11 zacks
Royal Gold, Inc. (RGLD - Free Report) has provided an update on third-quarter fiscal 2018 (ended Mar 31, 2018) operations. During the quarter, RGLD Gold AG, the fully-owned subsidiary of Royal Gold, sold roughly 63,000 gold equivalent ounces consisting of roughly 49,000 gold ounces, 272,000 silver ounces and 2,000 tons of copper related to its streaming agreements. The company ended the quarter with 26,000 ounces of gold and 659,000 ounces of silver, highlighting a sequential increase owing to late received deliveries.
Upvote Downvote

 
Analyzing Miners’ Implied Volatility

2018-04-10 marketrealist
Recently, the unrest in the markets has had a big effect on precious metals and the US dollar. The US dollar has a big impact on dollar-denominated precious metals and also on mining companies. In this part of the series, we’ll look at miners’ RSI (relative strength index) scores and implied volatility. The miners we’ve selected for our analysis are First Majestic Silver (AG), B2Gold (BTG), Royal Gold (RGLD), and Goldcorp (GG).
Upvote Downvote

2
Wheaton Precious Metals: What To Do Now

2018-04-09 seekingalpha
It was a strong quarter for the gold & silver streamer, but a disappointing year overall.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 780287108